[go: up one dir, main page]

AR091980A1 - Cepas mutantes de neospora y sus usos - Google Patents

Cepas mutantes de neospora y sus usos

Info

Publication number
AR091980A1
AR091980A1 ARP130102760A ARP130102760A AR091980A1 AR 091980 A1 AR091980 A1 AR 091980A1 AR P130102760 A ARP130102760 A AR P130102760A AR P130102760 A ARP130102760 A AR P130102760A AR 091980 A1 AR091980 A1 AR 091980A1
Authority
AR
Argentina
Prior art keywords
neospora
mutant
vints
function
protein
Prior art date
Application number
ARP130102760A
Other languages
English (en)
Inventor
Morisse-Philippe Solen
Seche Edouard
Lamarque Mauld
Breton Pascal
Boussemart-Prouvost Anne-France
Original Assignee
Vitamfero
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitamfero filed Critical Vitamfero
Publication of AR091980A1 publication Critical patent/AR091980A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Una cepa mutante de Neospora spp, en donde la función de la proteína McMIC3 y/o la función de la proteína NcMIC1 está suprimida, y a sus usos en una composición farmacéutica o en una composición de vacuna. Procedimiento in vitro de diagnóstico.
ARP130102760A 2012-08-02 2013-08-02 Cepas mutantes de neospora y sus usos AR091980A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1257544A FR2994193B1 (fr) 2012-08-02 2012-08-02 Souches mutantes de neospora et leurs utilisations

Publications (1)

Publication Number Publication Date
AR091980A1 true AR091980A1 (es) 2015-03-11

Family

ID=47429869

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130102760A AR091980A1 (es) 2012-08-02 2013-08-02 Cepas mutantes de neospora y sus usos

Country Status (11)

Country Link
US (1) US9603914B2 (es)
EP (1) EP2880051B1 (es)
CN (1) CN104822700B (es)
AR (1) AR091980A1 (es)
AU (1) AU2013298400B2 (es)
BR (1) BR112015002371A8 (es)
CA (1) CA2880867A1 (es)
ES (1) ES2755952T3 (es)
FR (1) FR2994193B1 (es)
NZ (1) NZ705408A (es)
WO (1) WO2014020291A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ726315A (en) 2014-05-14 2018-04-27 Merial Inc Methods for freeze-drying and rehydrating biologics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0841392B1 (en) * 1996-11-12 2004-07-14 Pfizer Inc. Attenuated live neospora vaccine
EP0953641A3 (en) * 1998-03-26 2002-03-13 Pfizer Products Inc. Polynucleotide molecules encoding neospora proteins
FR2864966B1 (fr) 2004-01-13 2006-05-05 Agronomique Inst Nat Rech Souches vaccinales d'apicomplexes de la famille des sarcocystidae.

Also Published As

Publication number Publication date
BR112015002371A8 (pt) 2018-01-16
US20150190487A1 (en) 2015-07-09
AU2013298400A1 (en) 2015-03-12
WO2014020291A2 (fr) 2014-02-06
AU2013298400B2 (en) 2017-12-21
FR2994193A1 (fr) 2014-02-07
WO2014020291A3 (fr) 2014-03-27
NZ705408A (en) 2017-12-22
BR112015002371A2 (pt) 2017-08-01
CN104822700A (zh) 2015-08-05
CN104822700B (zh) 2018-04-27
ES2755952T3 (es) 2020-04-24
EP2880051B1 (fr) 2019-10-09
CA2880867A1 (fr) 2014-02-06
FR2994193B1 (fr) 2016-05-20
EP2880051A2 (fr) 2015-06-10
US9603914B2 (en) 2017-03-28

Similar Documents

Publication Publication Date Title
CY1123404T1 (el) Αντι-girt αντισωματα
CR20120449A (es) Formas de rifaximina y sus usos
UY34350A (es) Derivados de pirazolquinolinona, su preparación y su uso terapéutico.
AU363796S (en) Nail care instruments
UY34721A (es) Anticuerpos anti-hla-b*27 y usos de éstos.
CR20140318A (es) Composiciones intranasales de dexmedetomidina y métodos de uso de ellas
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
BR112012010923A2 (pt) cepa de bifidobactéria
EA201390254A1 (ru) Модифицированные полипептиды релаксина и их применение
TWD198853S (zh) 口腔保健用具
CA2798214C (en) Vaccine against beta-herpesvirus infection and use thereof
MX2013011336A (es) Composiciones farmaceuticas intranasales de benzodiazepina.
MX2023006415A (es) Anticuerpos, usos y metodos.
UY36395A (es) Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso.
BR112015006731A2 (pt) combinações e usos das mesmas
CL2012003458A1 (es) Vector que comprende un polipeptido antigénico de campylobacter; composicion farmacéutica que comprende dicho vector; uso del vector para mejorar respuesta inmune del sujeto al polipéptido antigénico.
TWD166031S (zh) 口含物
UY34420A (es) ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"
EA201171186A1 (ru) Сокристалл этравирина и никотинамида
BR112016019389A8 (pt) Vacina, e, peptídeo
EP2843051A4 (en) ANTI-HUMAN CD69 ANTIBODY AND USE THEREOF FOR MEDICAL PURPOSES
CO6700840A2 (es) Teobromina en combinación con un expectorante o un mucolítico para su uso en terapia
CO2017007338A2 (es) Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina
RU2012102851A (ru) Штамм enterococcus durans вкпм в-8731, используемый для производства кисломолочных продуктов и пробиотических препаратов
TR201902547T4 (tr) Oksi̇dati̇f stresli̇ hastalarda parati̇roi̇d hormonunun ölçüm araçlari ve yöntemleri̇

Legal Events

Date Code Title Description
FB Suspension of granting procedure